ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
61,667.25
1.27%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Satsuma Pharmaceuticals Inc (STSA)

  7. Satsuma Pharmaceuticals Inc (STSA) News

Satsuma Pharmaceuticals (STSA)

Satsuma Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:STSA
DateTimeSourceHeadlineSymbolCompany
20/06/202318:03Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:STSASatsuma Pharmaceuticals Inc
15/06/202313:00GlobeNewswire Inc.Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific MeetingNASDAQ:STSASatsuma Pharmaceuticals Inc
12/06/202322:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
09/06/202311:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STSASatsuma Pharmaceuticals Inc
09/06/202311:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202321:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:20Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:19Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:18Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:17Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:15Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202314:12Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
31/05/202311:04Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
31/05/202311:03Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
26/05/202311:40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
25/05/202311:04Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:STSA

Your Recent History

LSE
ENET
Ethernity Networks
LSE
GKP
Gulf Keystone Petroleum
LSE
GOLD
LSE
VAST
Vast Resources
LSE
QBT
Quantum Blockchain Techn...
LSE
POS
Plexus
LSE
LLOY
Lloyds Banking
LSE
RKH
Rockhopper Exploration
LSE
GDR
Genedrive
LSE
TERN
Tern
LSE
AAZ
Anglo Asian Mining
LSE
HE1
Helium One Global
LSE
CHLL
Chill Brands
LSE
IGG
Ig
LSE
ANGS
Angus Energy
LSE
GGP
Greatland Gold
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved